Efficient gene targeting in Nicotiana tabacum using CRISPR/SaCas9 and temperature tolerant LbCas12a
Collection: Plant Genome Engineering: From Lab to Field | EK25
Credits: None available.
Type: Session
Speakers:
Vaccines against SARS-CoV-2: Current Status and Future Directions
Collection: COVID-19: One Year Later | EK32
Credits: None available.
Type: Session
Speakers:
Vaccines as Drugs for COVID‑19
Collection: eSymposia | Antibodies and Vaccines as Drugs for COVID-19
Credits: None available.
Type: Session
Speakers:
LEAPS Technology peptide vaccines activate T cells to elicit prophylaxis and therapy for SARS-CoV-2
Collection: eSymposia | Antibodies and Vaccines as Drugs for COVID-19
Credits: None available.
Type: Session
Speakers:
  • Ken S. Rosenthal, PhD, Augusta University/University of Georgia Medical Partnership
T-cell epitope-based subunit vaccine design in case of SARS-CoV-2 infection
Collection: eSymposia | Antibodies and Vaccines as Drugs for COVID-19
Credits: None available.
Type: Session
Speakers:
Collection: On Demand
Credits: None available.
Type: Session
Speakers:
Both adaptive immunity and IL-1R1 dependent signals improve clearance of cytosolic virulent mycobacteria in vivo.
Collection: eSymposia | Tuberculosis: Science Aimed at Ending the Epidemic
Credits: None available.
Type: Session
Speakers:
RD1 and RD9 Proteins and Peptides of Mycobacterium tuberculosis and Antibody Reactivity
Collection: eSymposia | Tuberculosis: Science Aimed at Ending the Epidemic
Credits: None available.
Type: Session
Speakers:
Short Talk: Personal Neoantigen Vaccines Induce Long-term Immune Responses in Patients with High Risk Melanoma
Collection: eSymposia | Advances in Cancer Immunotherapy
Credits: None available.
Type: Session
Speakers: